UK dividends calendar - next 7 days
24th Jul 2025 13:48
| Price | $0.906 on 22-08-2025 at 15:05:13 |
|---|---|
| Change | $0.01 1.12% |
| Buy | $0.91 |
| Sell | $0.902 |
| Last Trade: | Unknown 44,582.00 at $0.902332 |
| Day's Volume: | 597,223 |
| Last Close: | $0.896 |
| Open: | $0.886 |
| ISIN: | GB00BDGKMY29 |
| Day's Range | $0.886 - $0.908 |
| 52wk Range: | $0.80 - $0.94 |
| Market Capitalisation: | $1.02b |
| VWAP: | $0.902087 |
| Shares in Issue: | 1.13b |
Sector: Closed End Investments
Biopharma Cred. (BPCR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 44,582 | $0.902332 | Currency Conversion Negotiated Trade |
16:04:35 - 22-Aug-25 |
| Buy* | 24,894 | $0.906 | Automatic Execution |
15:53:00 - 22-Aug-25 |
| Unknown* | 34 | $0.904544 | Currency Conversion Negotiated Trade |
15:15:49 - 22-Aug-25 |
| Buy* | 142 | $0.906 | SI Trade |
14:59:29 - 22-Aug-25 |
| Buy* | 29,411 | $0.90432 | Ordinary |
14:22:27 - 22-Aug-25 |
| Unknown* | 12,000 | $0.898255 | Currency Conversion Negotiated Trade |
13:29:43 - 22-Aug-25 |
| Buy* | 87,700 | $0.90439 | Ordinary |
13:29:10 - 22-Aug-25 |
| Sell* | 20 | $0.90 | SI Trade |
13:26:41 - 22-Aug-25 |
| Unknown* | 20 | $0.90 | OTC Trade |
13:26:41 - 22-Aug-25 |
| Sell* | 111,851 | $0.898 | Ordinary |
13:21:07 - 22-Aug-25 |
Biopharma Cred. (BPCR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 21st Aug 2025 12:07 pm | RNS | Transaction in Own Shares - Correction |
| 20th Aug 2025 6:16 pm | RNS | Transaction in Own Shares |
| 12th Aug 2025 5:39 pm | RNS | Director/PDMR Shareholding |
| 31st Jul 2025 7:00 am | RNS | Appointment of New Director |
| 21st Jul 2025 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 18th Jul 2025 4:23 pm | RNS | Holding(s) in Company |
| 1st Jul 2025 12:02 pm | RNS | STATEMENT RE BIOCRYST |
| 24th Jun 2025 3:39 pm | RNS | Holding(s) in Company |
| 20th Jun 2025 4:00 pm | RNS | Net Asset Value(s) and Monthly Factsheet |
| 18th Jun 2025 7:00 am | RNS | Dividend Declaration |